News
The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...
8hon MSN
Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
11h
Medical Device Network on MSNAstraZeneca and Pangaea partner for AI detection of hypophosphatasiaAstraZeneca’s unit Alexion has partnered with Pangaea Data to fund the startup’s development of an AI tool for detecting HPP.
French drugmaker Sanofi SA (NASDAQ:SNY) on Monday said it is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure ...
19h
GlobalData on MSNEC approves AstraZeneca’s acalabrutinib combo for CLLThe EC has granted approval for a fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) plus venetoclax.
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
IonQ shares traded higher Monday after the company announced results of a collaborative research program with AstraZeneca, ...
9h
Zacks.com on MSNInnovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?Tempus AI surges 12.5% on new AI tools, a $200M AstraZeneca deal, and clinical data expansion- but is it time to buy?
2hon MSN
Sanjay Kumar Bohra has stepped down from his role as Chief Financial Officer (CFO) of Force Motors, effective June 9. The ...
The astraszenecaglobal.xyz scam is abusing the real pharmaceutical giant’s name to run a fake investment scheme targeting ...
IonQ (IONQ) announced results of a research program between the company, AstraZeneca (AZN), Amazon Web Services (AMZN) and Nvidia (NVDA).
A major challenge that the FTSE 100 continues to face is the very weak levels of liquidity in stocks traded in London.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results